Crossref journal-article
Springer Science and Business Media LLC
Nature Nanotechnology (297)
Bibliography

Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013). A biomimetic nanosponge that absorbs pore-forming toxins. Nature Nanotechnology, 8(5), 336–340.

Authors 5
  1. Che-Ming J. Hu (first)
  2. Ronnie H. Fang (additional)
  3. Jonathan Copp (additional)
  4. Brian T. Luk (additional)
  5. Liangfang Zhang (additional)
References 27 Referenced 649
  1. Clatworthy, A. E., Pierson, E. & Hung, D. T. Targeting virulence: a new paradigm for antimicrobial therapy. Nature Chem. Biol. 3, 541–548 (2007). (10.1038/nchembio.2007.24) / Nature Chem. Biol. by AE Clatworthy (2007)
  2. Rasko, D. A. & Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nature Rev. Drug Discov. 9, 117–128 (2010). (10.1038/nrd3013) / Nature Rev. Drug Discov. by DA Rasko (2010)
  3. Beghini, D. G. et al. Anti-sera raised in rabbits against crotoxin and phospholipase A2 from Crotalus durissus cascavella venom neutralize the neurotoxicity of the venom and crotoxin. Toxicon 44, 141–148 (2004). (10.1016/j.toxicon.2004.05.011) / Toxicon by DG Beghini (2004)
  4. Chen, Z. et al. Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding. Proc. Natl Acad. Sci. USA 106, 13487–13492 (2009). (10.1073/pnas.0906581106) / Proc. Natl Acad. Sci. USA by Z Chen (2009)
  5. McCormick, C. C., Caballero, A. R., Balzli, C. L., Tang, A. & O'Callaghan, R. J. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Invest. Ophthalmol. Vis. Sci. 50, 2848–2854 (2009). (10.1167/iovs.08-3157) / Invest. Ophthalmol. Vis. Sci. by CC McCormick (2009)
  6. Hung, D. T., Shakhnovich, E. A., Pierson, E. & Mekalanos, J. J. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670–674 (2005). (10.1126/science.1116739) / Science by DT Hung (2005)
  7. Hoshino, Y. et al. The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo. Proc. Natl Acad. Sci. USA 109, 33–38 (2012). (10.1073/pnas.1112828109) / Proc. Natl Acad. Sci. USA by Y Hoshino (2012)
  8. Gilbert, R. J. Pore-forming toxins. Cell Mol. Life Sci. 59, 832–844 (2002). (10.1007/s00018-002-8471-1) / Cell Mol. Life Sci. by RJ Gilbert (2002)
  9. Rosado, C. J. et al. The MACPF/CDC family of pore-forming toxins. Cell Microbiol. 10, 1765–1774 (2008). (10.1111/j.1462-5822.2008.01191.x) / Cell Microbiol. by CJ Rosado (2008)
  10. Shoham, M. Antivirulence agents against MRSA. Future Med. Chem. 3, 775–777 (2011). (10.4155/fmc.11.43) / Future Med. Chem. by M Shoham (2011)
  11. O'Hanley, P., Lalonde, G. & Ji, G. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect. Immun. 59, 1153–1161 (1991). (10.1128/IAI.59.3.1153-1161.1991) / Infect. Immun. by P O'Hanley (1991)
  12. Edelson, B. T. & Unanue, E. R. Intracellular antibody neutralizes Listeria growth. Immunity 14, 503–512 (2001). (10.1016/S1074-7613(01)00139-X) / Immunity by BT Edelson (2001)
  13. Nakouzi, A., Rivera, J., Rest, R. F. & Casadevall, A. Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis. BMC Microbiol. 8, 159–168 (2008). (10.1186/1471-2180-8-159) / BMC Microbiol. by A Nakouzi (2008)
  14. Kirkham, L. A. et al. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immun. 74, 586–593 (2006). (10.1128/IAI.74.1.586-593.2006) / Infect. Immun. by LA Kirkham (2006)
  15. Andreeva-Kovalevskaya, Zh. I., Solonin, A. S., Sineva, E. V. & Ternovsky, V. I. Pore-forming proteins and adaptation of living organisms to environmental conditions. Biochemistry (Mosc) 73, 1473–1492 (2008). (10.1134/S0006297908130087) / Biochemistry (Mosc) by ZhI Andreeva-Kovalevskaya (2008)
  16. Bayley, H. Membrane–protein structure: piercing insights. Nature 459, 651–652 (2009). (10.1038/459651a) / Nature by H Bayley (2009)
  17. Hu, C. M. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980–10985 (2011). (10.1073/pnas.1106634108) / Proc. Natl Acad. Sci. USA by CM Hu (2011)
  18. Bhakdi, S., Tranum-Jensen, J. & Sziegoleit, A. Mechanism of membrane damage by streptolysin-O. Infect. Immun. 47, 52–60 (1985). (10.1128/IAI.47.1.52-60.1985) / Infect. Immun. by S Bhakdi (1985)
  19. Dempsey, C. E. The actions of melittin on membranes. Biochim. Biophys. Acta 1031, 143–161 (1990). (10.1016/0304-4157(90)90006-X) / Biochim. Biophys. Acta by CE Dempsey (1990)
  20. Klainer, A. S., Madoff, M. A., Cooper, L. Z. & Weinstein, L. Staphylococcal alpha-hemolysin: detection on the erythrocyte membrane by immunofluorescence. Science 145, 714–715 (1964). (10.1126/science.145.3633.714) / Science by AS Klainer (1964)
  21. Moorjani, M. et al. Nanoerythrosomes, a new derivative of erythrocyte ghost II: identification of the mechanism of action. Anticancer Res. 16, 2831–2836 (1996). / Anticancer Res. by M Moorjani (1996)
  22. Gao, W., Langer, R. & Farokhzad, O. C. Poly(ethylene glycol) with observable shedding. Angew. Chem. Int. Ed. 49, 6567–6571 (2010). (10.1002/anie.201001868) / Angew. Chem. Int. Ed. by W Gao (2010)
  23. Bhakdi, S. & Tranum-Jensen, J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55, 733–751 (1991). (10.1128/MMBR.55.4.733-751.1991) / Microbiol. Rev. by S Bhakdi (1991)
  24. Gill, D. M. Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 46, 86–94 (1982). (10.1128/MMBR.46.1.86-94.1982) / Microbiol. Rev. by DM Gill (1982)
  25. Watanabe, M., Tomita, T. & Yasuda, T. Membrane-damaging action of staphylococcal alpha-toxin on phospholipid-cholesterol liposomes. Biochim. Biophys. Acta 898, 257–265 (1987). (10.1016/0005-2736(87)90065-4) / Biochim. Biophys. Acta by M Watanabe (1987)
  26. Pornpattananangkul, D. et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Am. Chem. Soc. 133, 4132–4139 (2011). (10.1021/ja111110e) / J. Am. Chem. Soc. by D Pornpattananangkul (2011)
  27. Leroux, J. C. Injectable nanocarriers for biodetoxification. Nature Nanotech. 2, 679–684 (2007). (10.1038/nnano.2007.339) / Nature Nanotech. by JC Leroux (2007)
Dates
Type When
Created 12 years, 4 months ago (April 14, 2013, 2:57 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 7:39 p.m.)
Indexed 1 week ago (Aug. 31, 2025, 6:39 a.m.)
Issued 12 years, 4 months ago (April 14, 2013)
Published 12 years, 4 months ago (April 14, 2013)
Published Online 12 years, 4 months ago (April 14, 2013)
Published Print 12 years, 4 months ago (May 1, 2013)
Funders 0

None

@article{Hu_2013, title={A biomimetic nanosponge that absorbs pore-forming toxins}, volume={8}, ISSN={1748-3395}, url={http://dx.doi.org/10.1038/nnano.2013.54}, DOI={10.1038/nnano.2013.54}, number={5}, journal={Nature Nanotechnology}, publisher={Springer Science and Business Media LLC}, author={Hu, Che-Ming J. and Fang, Ronnie H. and Copp, Jonathan and Luk, Brian T. and Zhang, Liangfang}, year={2013}, month=apr, pages={336–340} }